ABDEL KADER ABDEL KADER
Pharmacist in WEST PALM BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: ABDEL KADER ABDEL KADER filed 126 Medicare Part D claims in 2023 across WEST PALM BEACH, Florida. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
ABDEL KADER ABDEL KADER at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Florida
How Pharmacist compares to other specialties among Florida providers
Pharmacist share within Florida
Pharmacist is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pharmacist ABMS/AOA estimate
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pharmacist US NPIs
Specialty board-certified rate — Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ABDEL KADER ABDEL KADER is a Pharmacist provider practicing in WEST PALM BEACH, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1699439364. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
ABDEL KADER ABDEL KADER appears in the CMS NPPES registry as a Pharmacist provider at 760 EXECUTIVE DRIVE, WEST PALM BEACH, FL, 33401, with a listed phone of (787) 214-8775. NPI 1699439364 was issued on 10/28/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ABDEL KADER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 126 prescription claims written by this provider, covering 111 Medicare beneficiaries and totaling roughly $34K in drug spend, split 98% brand-name and 2% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1699439364 |
|---|---|
| Specialty | Pharmacist |
| Gender | Male |
| NPI Issued | 10/28/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ABDEL KADER ABDEL KADER's current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ABDEL KADER ABDEL KADER. To verify ABDEL KADER ABDEL KADER's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
98% brand-name claims vs 2% generic, on 126 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 130
- Total Day Supply
- 333
- Brand vs Generic
- 98% brand / 2% generic
- Brand Drug Cost
- $34K
Patient Demographics
- Average Patient Age
- 76.5 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 57% female / 43% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Arexvy Rsvpref3 Antigen/As01e/Pf | 72 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How ABDEL KADER ABDEL KADER fits within the Pharmacist landscape nationally.
ABDEL KADER ABDEL KADER's 126 claims are below the specialty average of 135.
Nearby Pharmacist Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as ABDEL KADER.
Compare Pharmacist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is ABDEL KADER ABDEL KADER's specialty? ▼
How much does ABDEL KADER ABDEL KADER prescribe under Medicare Part D? ▼
Where is ABDEL KADER ABDEL KADER located? ▼
What is ABDEL KADER ABDEL KADER's NPI number? ▼
Does ABDEL KADER ABDEL KADER prescribe more brand-name or generic drugs? ▼
How many Pharmacist providers are there in the US? ▼
What drugs does ABDEL KADER ABDEL KADER prescribe most often? ▼
Does ABDEL KADER ABDEL KADER accept Medicare? ▼
How can I verify ABDEL KADER ABDEL KADER's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology